Hematopoietic recovery of acute radiation syndrome by human superoxide dismutase-expressing umbilical cord mesenchymal stromal cells

Cytotherapy

Volumn 17, Issue 4, 2015, Pages 403-417

  Gan, Jingyi ^a   Meng, Fanwei ^a   Zhou, Xin ^a   Li, Chan ^a   He, Yixin ^a   Zeng, Xiaoping ^a   Jiang, Xingen ^a   Liu, Jia ^a   Zeng, Guifang ^a   Tang, Yunxia ^a   Liu, Muyun ^a   Mrsny, Randall J ^c,d   Hu, Xiang ^a   Hu, Jifan ^b,c   Li, Tao ^a  

^a Shenzhen Beike Cell Engineering Research Institute   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GMR Epigenetics Corporation   (United States)

^d University of Bath   (United Kingdom)

Author keywords

Acute radiation syndrome; Apoptosis; Hematopoietic failure; Stem cell; Superoxide dismutase; Umbilical cord mesenchymal stromal cells

Indexed keywords

EXTRACELLULAR SUPEROXIDE DISMUTASE; RADIOPROTECTIVE AGENT; SUPEROXIDE DISMUTASE;

ACUTE RADIATION SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANTIOXIDANT ASSAY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL PROTECTION; CELL THERAPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; THERAPY EFFECT; TISSUE INJURY; TREATMENT RESPONSE; UMBILICAL CORD; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PROCEDURES;

MUS;

ACUTE RADIATION SYNDROME; ANIMALS; APOPTOSIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; RADIATION-PROTECTIVE AGENTS; SUPEROXIDE DISMUTASE; UMBILICAL CORD;

EID: 84924284032     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.11.011     Document Type: Article

References (43)

1. Christodouleas J.P., Forrest R.D., Ainsley C.G., Tochner Z., Hahn S.M., Glatstein E. Short-Term and Long-Term Health Risks of Nuclear-Power-Plant Accidents. NEngl J Med 2011, 364:2334-2341.
2. Saha S., Bhanja P., Kabarriti R., Liu L., Alfieri A.A., Guha C. Bone Marrow Stromal Cell Transplantation Mitigates Radiation-Induced Gastrointestinal Syndrome in Mice. PLoS One 2011, 6:e24072.
3. Fouillard L., Chapel A., Bories D., Bouchet S., Costa J.M., Rouard H., et al. Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia 2007, 21:568-570.
4. Fouillard L., Francois S., Bouchet S., Bensidhoum M., Elm'selmi A., Chapel A. Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of mesenchymal stem cells post-treatment reduces hematopoietic toxicity and promotes hematopoietic reconstitution. Curr Pharm Biotechnol 2014, 14:842-848.
5. Romanov Y.A., Svintsitskaya V.A., Smirnov V.N. Searching for Alternative Sources of Postnatal Human Mesenchymal Stem Cells: Candidate MSC-Like Cells from Umbilical Cord. Stem Cells 2003, 21:105-110.
6. Mitchell K.E., Weiss M.L., Mitchell B.M., Martin P., Davis D., Morales L., et al. Matrix Cells from Wharton's Jelly Form Neurons and Glia. Stem Cells 2003, 21:50-60.
7. Santos Nascimento D., Mosqueira D., Sousa L.M., Teixeira M., Filipe M., Resende T.P., et al. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms. Stem Cell Res Ther 2014, 5:5.
8. Yang B., Bai B., Liu C.X., Wang S.Q., Jiang X., Zhu C.L., et al. Effect of umbilical cord mesenchymal stem cells on treatment of severe acute pancreatitis in rats. Cytotherapy 2013, 15:154-162.
9. Liu Z., Meng F., Li C., Zhou X., Zeng X., He Y., et al. Human umbilical cord mesenchymal stromal cells rescue mice from acetaminophen-induced acute liver failure. Cytotherapy 2014, 16:1207-1219.
10. Liu J., Han D., Wang Z., Xue M., Zhu L., Yan H., et al. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells. Cytotherapy 2013, 15:185-191.
11. + Umbilical Cord Matrix Cells. Stem Cells 2007, 25:98-106.
12. Voswinkel J., Francois S., Gorin N.C., Chapel A. Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells. Immunol Res 2013, 56:241-248.
13. Shalaby S.M., El-Shal A.S., Abd-Allah S.H., Selim A.O., Selim S.A., Gouda Z.A., et al. Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli-induced acute lung injury in mice. Cytotherapy 2014, 16:764-775.
14. Venugopal S.K., Wu J., Catana A.M., Eisenbud L., He S.Q., Duan Y.Y., et al. Lentivirus-mediated superoxide dismutase1 gene delivery protects against oxidative stress-induced liver injury in mice. Liver Int 2007, 27:1311-1322.
15. He S.Q., Zhang Y.H., Venugopal S.K., Dicus C.W., Perez R.V., Ramsamooj R., et al. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transpl 2006, 12:1869-1879.
16. Chen M., Zhang H., Wu J., Xu L., Xu D., Sun J., et al. Promotion of the induction of cell pluripotency through metabolic remodeling by thyroid hormone triiodothyronine-activated PI3K/AKT signal pathway. Biomaterials 2012, 33:5514-5523.
17. Amable P., Teixeira M.V., Carias R.B., Granjeiro J.M., Borojevic R. Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Res Ther 2014, 5:53.
18. Yao X., Hu J.F., Daniels M., Yien H., Lu H., Sharan H., et al. ANovel Orthotopic Tumor Model to Study Growth Factors and Oncogenes in Hepatocarcinogenesis. Clin Cancer Res 2003, 9:2719-2726.
19. Chapel A., Bertho J.M., Bensidhoum M., Fouillard L., Young R.G., Frick J., et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. JGene Med 2003, 5:1028-1038.
20. Li N., Yang H., Lu L., Duan C., Zhao C., Zhao H. Comparison of the labeling efficiency of BrdU, DiI and FISH labeling techniques in bone marrow stromal cells. Brain Res 2008, 1215:11-19.
21. Chen H.L., Li T., Qiu X.W., Wu J., Ling J.Q., Sun Z.H., et al. Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. EMBO J 2006, 25:5329-5338.
22. Li T., Hu J.F., Qiu X., Ling J., Chen H., Wang S., et al. CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex-2 intrachromosomal loop. Mol Cell Biol 2008, 28:6473-6482.
23. Hu J.F., Oruganti H., Vu T.H., Hoffman A.R. Tissue-specific imprinting of the mouse insulin-like growth factor II receptor gene correlates with differential allele-specific DNA methylation. Mol Endocrinol 1998, 12:220-232.
24. Hu J.F., Vu T.H., Hoffman A.R. Promoter-specific Modulation of Insulin-like Growth Factor II Genomic Imprinting by Inhibitors of DNA Methylation. JBiol Chem 1996, 271:18253-18262.
25. Barberini D., Freitas N.P., Magnoni M.S., Maia L., Listoni A.J., Heckler M.C., et al. Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential. Stem Cell Res Ther 2014, 5:25.
26. Brown S.L., Kolozsvary A., Liu J., Ryu S., Kim J.H. Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice. Radiat Res 2008, 169:474-478.
27. Chen S., Xu Y., Wang S., Shen M., Chen F., Chen M., et al. Subcutaneous administration of rhIGF-I post irradiation exposure enhances hematopoietic recovery and survival in BALB/c mice. JRadiat Res 2012, 53:581-587.
28. Wang Y., Liu L., Pazhanisamy S.K., Li H., Meng A., Zhou D. Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. Free Radic Biol Med 2010, 48:348-356.
29. Kiang J.G., Zhai M., Liao P.J., Bolduc D.L., Elliott T.B., Gorbunov N.V. Pegylated G-CSF Inhibits Blood Cell Depletion, Increases Platelets, Blocks Splenomegaly, and Improves Survival after Whole-Body Ionizing Irradiation but Not after Irradiation Combined with Burn. Oxid Med Cell Longev 2014, 2014:10.
30. Pazhanisamy S.K., Li H., Wang Y., Batinic-Haberle I., Zhou D. NADPH oxidase inhibition attenuates total body irradiation-induced haematopoietic genomic instability. Mutagenesis 2011, 26(3):431-435.
31. Li H., Wang Y., Pazhanisamy S.K., Shao L., Batinic-Haberle I., Meng A., et al. Mn(III) meso-tetrakis-(N-ethylpyridinium-2-yl) porphyrin mitigates total body irradiation-induced long-term bone marrow suppression. Free Radic Biol Med 2011, 51:30-37.
32. Day R.M., Barshishat-Kupper M., Mog S.R., McCart E.A., Prasanna P.G., Davis T.A., et al. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. JRadiat Res 2008, 49:361-372.
33. Plett P.A., Sampson C.H., Chua H.L., Joshi M., Booth C., Gough A., et al. Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome. Health Phys 2012, 103:343-355.
34. Poncin G., Beaulieu A., Humblet C., Thiry A., Oda K., Boniver J., et al. Characterization of Spontaneous Bone Marrow Recovery after Sublethal Total Body Irradiation: Importance of the Osteoblastic/Adipocytic Balance. PLoS ONE 2012, 7:e30818.
35. Ghoneum M., Badr El-Din N.K., Abdel Fattah S.M., Tolentino L. Arabinoxylan rice bran (MGN-3/Biobran) provides protection against whole-body γ-irradiation in mice via restoration of hematopoietic tissues. JRadiat Res 2013, 54:419-429.
36. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science 1999, 284:143-147.
37. Hu K.X., Sun Q.Y., Guo M., Ai H.S. The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury. Br J Radiol 2010, 83:52-58.
38. Aquino J.B., Bolontrade M.F., García M.G., Podhajcer O.L., Mazzolini G. Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. Gene Ther 2010, 17:692-708.
39. Piao W., Wang H., Inoue M., Hasegawa M., Hamada H., Huang J. Transplantation of sendai viral angiopoietin-1-modified mesenchymal stem cells for ischemic limb disease. Angiogenesis 2010, 13:203-210.
40. Lange C., Brunswig-Spickenheier B., Cappallo-Obermann H., Eggert K., Gehling U.M., Rudolph C., et al. Radiation Rescue: Mesenchymal Stromal Cells Protect from Lethal Irradiation. PLoS One 2011, 6:e14486.
41. Abdel-Mageed A.S., Senagore A.J., Pietryga D.W., Connors R.H., Giambernardi T.A., Hay R.V., et al. Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice. Blood 2009, 113:1201-1203.
42. Agrawal R.S., Muangman S., Layne M.D., Melo L., Perrella M.A., Lee R.T., et al. Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival. Gene Ther 2004, 11:962-969.
43. Shao L., Li H., Pazhanisamy S.K., Meng A., Wang Y., Zhou D. Reactive oxygen species and hematopoietic stem cell senescence. Int J Hematol 2011, 94:24-32.